Unknown

Dataset Information

0

Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.


ABSTRACT: Murine models of Neisseria gonorrhoeae lower reproductive tract infection are valuable systems for studying N. gonorrhoeae adaptation to the female host and immune responses to infection. These models have also accelerated preclinical testing of candidate therapeutic and prophylactic products against gonorrhea. However, because N. gonorrhoeae infection is restricted to the murine cervicovaginal region, there is a need for an in vivo system for translational work on N. gonorrhoeae pelvic inflammatory disease (PID). Here we discuss the need for well-characterized preclinical upper reproductive tract infection models for developing candidate products against N. gonorrhoeae PID, and report a refinement of the gonorrhea mouse model that supports sustained upper reproductive tract infection. To establish this new model for vaccine testing, we also tested the licensed meningococcal 4CMenB vaccine, which cross-protects against murine N. gonorrhoeae lower reproductive tract infection, for efficacy against N. gonorrhoeae in the endometrium and oviducts following transcervical or vaginal challenge.

SUBMITTER: Connolly KL 

PROVIDER: S-EPMC8365121 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.

Connolly Kristie L KL   Pilligua-Lucas Michelle M   Gomez Carolina C   Costenoble-Caherty Allison C AC   Soc Anthony A   Underwood Knashka K   Macintyre Andrew N AN   Sempowski Gregory D GD   Jerse Ann E AE  

The Journal of infectious diseases 20210801 12 Suppl 2


Murine models of Neisseria gonorrhoeae lower reproductive tract infection are valuable systems for studying N. gonorrhoeae adaptation to the female host and immune responses to infection. These models have also accelerated preclinical testing of candidate therapeutic and prophylactic products against gonorrhea. However, because N. gonorrhoeae infection is restricted to the murine cervicovaginal region, there is a need for an in vivo system for translational work on N. gonorrhoeae pelvic inflamma  ...[more]

Similar Datasets

| S-EPMC6177736 | biostudies-literature
| S-EPMC10321600 | biostudies-literature
| S-EPMC9241707 | biostudies-literature
| S-EPMC5377941 | biostudies-literature
| PRJEB24147 | ENA
| S-EPMC4192600 | biostudies-literature
| S-EPMC8672594 | biostudies-literature
| S-EPMC6761111 | biostudies-literature
| S-EPMC10985838 | biostudies-literature
| S-EPMC5976782 | biostudies-literature